Shah Meet, Hashemi Ashkan, Afriyie Felix, Singh Inderjit, Kim Hyoeun, Aziz Emad F
Department of Cardiology, Rutgers New Jersey Medical School, Newark, NJ, USA.
J Innov Card Rhythm Manag. 2023 Aug 15;14(8):5558-5562. doi: 10.19102/icrm.2023.14084. eCollection 2023 Aug.
The Micra™ leadless pacemaker (Medtronic, Minneapolis, MN, USA) is indicated for the management of symptomatic bradycardia and advanced heart block. However, the safety of this procedure during pregnancy has not been studied. Here, we present a unique case of Micra™ leadless pacemaker implantation (MLP) in a 31 weeks pregnant patient with intermittent complete heart block who presented with multiple syncopal episodes. The patient underwent an MLP implantation with <40 mGy radiation exposure (about 0.6 min of total fluoroscopy time), which is deemed a negligible dose of radiation exposure during pregnancy. Her subsequent hospital course was uneventful, and she was safely discharged home and was able to continue her pregnancy and delivery without further syncopal episodes or incidence of heart block.
美敦力公司(位于美国明尼苏达州明尼阿波利斯市)的Micra™无导线起搏器适用于有症状的心动过缓和高度心脏传导阻滞的治疗。然而,该手术在孕期的安全性尚未得到研究。在此,我们报告一例独特病例,一名孕31周、间歇性完全性心脏传导阻滞且有多次晕厥发作的患者接受了Micra™无导线起搏器植入术(MLP)。该患者接受MLP植入时的辐射暴露<40毫戈瑞(总透视时间约0.6分钟),这被认为是孕期可忽略不计的辐射剂量。她随后的住院过程平稳,安全出院,并能够继续妊娠和分娩,未再出现晕厥发作或心脏传导阻滞情况。